Importance The emerging paradigm of treat-to-target in psoriasis requires accurate
monitoring of treatment response. The commonly used physician global assessment tool …

Biologic therapies like adalimumab are the gold standard for psoriasis treatment with
efficacy and safety profiles allowing for long-term treatment. However, adalimumab cannot …

Importance Few studies have compared the use of methotrexate and biologics, the most
commonly used systemic medications for treatment of moderate to severe psoriasis in …

Background: Little is known about the treatment outcomes of secukinumab in clinical
practice, which differ from those in clinical trials. The effectiveness of biologics may differ in …

The advances in psoriasis management currently allow achieving a good control of the
disease. In particular, with the latest developed molecules, available evidence suggests that …

Background: Psoriasis is a multifactorial immune-mediated inflammatory disease, with a
chronic relapsing-remitting course, which affects 2-3% of the worldwide population …

Abstract Background Biological therapies (BTs) including infliximab (IFX), adalimumab
(ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment …

Background Treatment modifications, including dose escalations, dose reductions, switches,
discontinuations and restarts of biologics may be necessary in the management of psoriasis …

Background The efficacy of etanercept and ustekinumab in psoriasis has been compared in
one randomized controlled trial. Comparison of the long‐term effectiveness of biologics in …

Depression and Insomnia in Patients With Psoriasis and Psori... : Medicine Depression and
Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor …